ABOUT
In this episode of Breaking Brad, Brad and drug pricing expert Alex Gelfand, PharmD, attempt to demystify the opaque worlds of drug pricing and health insurance in the United States. They discuss the chain of custody for a drug—from the manufacturer to the patient who picks it up at the pharmacy—and highlight the many “hands in the pocket” along the way. They discuss the powerful role pharmacy benefit managers (PBMs) play in the pricing, as well as insurance companies that own every link of the drug custody chain. They argue for greater transparency and simpler distribution models using examples such as Mark Cuban’s Cost Plus Pharmacy.
TAKEAWAYS
Drug pricing is a complex issue influenced by multiple stakeholders.
Pharmacy education involves rigorous training and a deep understanding of medications.
Insurance companies play a significant role in determining drug prices and coverage.
Formularies dictate what medications are covered by insurance plans.
Prior authorizations can create barriers for patients seeking necessary medications.
The patient experience is often fraught with confusion and frustration regarding drug costs.
Pharmacy Benefit Managers (PBMs) significantly impact drug pricing and access.
Transparency in drug pricing is lacking, leading to distrust among patients.
Global comparisons reveal different approaches to drug pricing and healthcare.
Innovative models like Mark Cuban’s Cost Plus Pharmacy show potential for reform.
Episode timeline
- 00:00 Introduction to Drug Pricing and Health Insurance
- 00:00 Understanding the Pharmacy Education Pathway
- 00:00 The Complexity of Drug Pricing
- 00:00 The Role of Insurance Companies in Drug Pricing
- 00:00 Navigating Formularies and Patient Coverage
- 00:00 The Impact of Prior Authorizations
- 00:00 The Patient Experience with Drug Pricing
- 00:00 The Role of Pharmacy Benefit Managers (PBMs)
- 00:00 The Transparency Issue in Drug Pricing
- 00:00 Comparing Drug Pricing Systems Globally
- 00:00 The Influence of Rebates on Drug Prices
- 00:00 The Ticketmaster Analogy for Drug Pricing
- 00:00 The Future of Drug Pricing and Potential Solutions
